TCT RUSSIA 2021
cardiomedics

10
years
TCT RUSSIA
10
years

CARDIOMEDICS Ltd.

Pokrovsky blvd., 4/17, office 40, 101000 Moscow, Russia

+7 (495) 935-84-71

+7 (495) 935-84-72

info@cardiomedics.ru

www.cardiomedics.ru

Company details

For more than 15 years CARDIOMEDICS Ltd. is the authorized distributor of Boston Scientific Corp. the world leader in development and manufacturing of instruments for interventional cardiology and cardiac rhythm management as well as for peripheral interventions and interventional oncology.

Coronary stents portfolio (PtCr DES coated with biostable polymer matrix and Everolimus, optimal visibility, minimal recoil, enhanced radial force - Promus Premier, Promus Elite) has been extended by Synergy XD and Megatron with original design with low polymer burden, ultra-thin abluminal bioabsorbable polymer eluting Everolimus, which mitigate the risk of thrombosis and reduce the need for extended dual antiplatelet therapy.

Boston Scientific balloon catheters portfolio (Maverick², Emerge, Quantum Apex, Quantum Maverick and NC Emerge) support all stages including delivery of targeted therapeutic dose of proven anti-proliferative Paclitaxel to the lesion by drug-coated balloon catheter Agent. It is manufactured utilizing TransPax technology.

To facilitate interventional instrumentation delivery to target lesion there is original Guide Extension Catheter Guidezilla.

Coronary guidewires Sentai designed in cooperation with Japanese engineers are the product of choice both for routine procedures (Marvel, Samurai) and for complex PCI including guidewires for total occlusions recanalization (Samurai RC, Fighter, Hornet, Hornet 10, Hornet 14).

Company’s portfolio supports technologies which are used to optimize PTCA and stenting procedures: intravascular ultra-sound system (iLab) with updated software Virtual Histology, rotational atherectomy (Rotablator), cutting balloon catheters (Wolverine) as well as unique technology to recanalize coronary CTOs. CrossBoss and Stingray Coronary CTO Crossing and Re-Entry devices allow to accurately target and re-enter the true lumen from a subintimal position and treat CTOs safely, with maximum efficiency and success. New coronary microcatheters Mamba and Mamba Flex are offered for both the antegrade and retrograde recanalization techniques.

Peripheral intervention product range includes balloon catheters Coyote designed for lower limb vessels, balloon catheter Mustang for iliac and femoral arteries, peripheral guidewires V-14 ControlWire, V-18 ControlWire. Peripheral product portfolio has been recently supplemented by .018” drug-coated balloon catheter Ranger and support catheter Rubicon. Peripheral nitinol stents by Boston Scientific provide different options to gain optimal results. Thus hi-tech peripheral stent Innova is designed for tibial artery implantation, Epic is considered to be optimal for iliac arteries. Recently approved in RF Eluvia (Paclitaxel eluting) has demonstrated premium clinical results based on 3-years randomized clinical study. The new Jetstream atherectomy system is recently approved for Russian Federation market and intended for multiple lesion morphologies including calcium, plaque or thrombus. The high-tech device design allows utilization of one catheter in different areas of the extended lesion in CLI patients. The multifunctional principle of this atherectomy system provides high safety and efficiency of the peripheral interventions.

WATCHMAN Left Atrium Appendage Closure technology to prevent thromboembolic complications at atrial fibrillation is acknowledged as extremely effective. And this is the only LAA closure device which is proved alternative to warfarin therapy.

TAVR system ACURATE neo has the following distinctive features: self-expanding structure with porcine pericardium leaflets, supra-annular design, easy implantation due to top-down deployment, sustained atrial blood flow and easy and reliable locking system. ACURATE neo has proved to be one of the most optimal safety and clinical effectiveness wise.

Boston Scientific also offers oncology solution - The Visual ICE System is indicated for use as a cryosurgical tool in the fields of general surgery, dermatology, neurology (including cryoanalgesia), thoracic surgery (with the exception of cardiac tissue), ENT, gynecology, oncology, proctology, and urology. This system is designed to destroy tissue (including prostate and kidney tissue, liver metastases, tumors, and skin lesions) by the application of extremely cold temperatures.

CARDIOMEDICS Ltd. is the authorized distributor of Stryker Neurovascular promoting advanced technologies and instruments in endovascular neurosurgery. Cooperation with Stryker Neurovascular allowed for introducing in Russian market highly effective technologies and instruments for endovascular thrombectomy as the treatment approach to acute ischemic stroke which has reached the highest level of evidence and the IA class of indications in foreign and national recommendations in 2015. Trevo XP ProVue retriever has demonstrated the highest efficacy and safety in the main randomized studies and registers. In 2020 Flow Diverters designed for treatment of intracranial intrasaccular aneurysms has been added by new model Surpass Evolve. CARDIOMEDICS LLC. provides integrated approach to endovascular thrombaspiration in AIS: Dominant Flex pump allowing for high-vacuum reliable suction and AXS Catalyst 6 F aspiration catheter with ID 0,060” inches and hyper-flexible distal segment.

Since 2018 Cardiomedics LLC is also distributing devices for endovascular treatment of structural heart diseases in grown-up and children produced by Occlutech GmbH – the world leader in SH occluders industry. All Occlutech devices demonstrate a set of unique technical features providing the optimal combination of ultimate usability, safety and efficiency. The line of devices includes the occluders for minimally invasive closure of the patent foramen ovale Occlutech Figulla Flex II PFO, atrial septal defects Occlutech Figulla Flex II ASD and Occlutech Figulla Flex II UNI, patent ductus arteriosus Occlutech PDA and a device that has no analogues on the market for endovascular paravalvular leaks closure Occlutech PLD.

CARDIOMEDICS Ltd. as the authorized distributor of Impulse Dynamics – manufacturer offering innovative solutions for treatment of Chronic Heart Failure (CHF) has successfully launched implantable device for Cardiac Contractility Modulation (CCM) therapy Optimizer. The device delivers nonexcitatory electrical pulses and indicated for adult patients with CHF resulting from LV dysfunction. Therapy is resulted in restoring the mechanical function of cardiomyocytes, ejection fraction incrementation, HF functional class decrease, better exercise capacity, myocardium reverse remodeling and better life quality.

Return